Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results

New treatment modalities with vaccine therapy in renal cell carcinoma

A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma

Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine

Randomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.

Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma